Patents by Inventor Susan L. Andersen

Susan L. Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC IMPRINTING FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
    Publication number: 20110224256
    Abstract: The invention features methods, kits, and compositions for the treatment of psychiatric disorders using therapeutic imprinting in pre-pubescent subjects.
    Type: Application
    Filed: June 12, 2009
    Publication date: September 15, 2011
    Inventor: Susan L. Andersen
  • CORTICOSTEROID CONJUGATES AND USES THEREOF
    Publication number: 20100056488
    Abstract: The invention features corticosteroids conjugated to either a charged group or a bulky group in a manner that resists in vivo cleavage, the resulting conjugate is a peripherally acting steroid with reduced activity in the central nervous system. The invention provides a method for treating a patient having an inflammatory disease by administering to the patient a corticosteroid conjugate.
    Type: Application
    Filed: November 4, 2009
    Publication date: March 4, 2010
    Applicant: The McLean Hospital Corporation
    Inventors: Martin H. Teicher, Susan L. Andersen-Navalta
  • Methods for the Treatment of ADHD and Related Disorders
    Publication number: 20090221552
    Abstract: The invention features methods, compositions, and kits for the treatment of attention deficit hyperactivity disorder and related behavioral disorders by administering an organic cation 3 (hOCT3) inhibitor.
    Type: Application
    Filed: February 27, 2007
    Publication date: September 3, 2009
    Applicant: The McLean Hospital Corporation
    Inventors: Martin Teicher, Susan L. Andersen, Jacqueline A. Samson
  • Corticosteroid conjugates and uses thereof
    Publication number: 20040157810
    Abstract: The invention features corticosteroids conjugated to either a charged group or a bulky group in a manner that resists in vivo cleavage, the resulting conjugate is a peripherally acting steroid with reduced activity in the central nervous system. The invention provides a method for treating a patient having an inflammatory disease by administering to the patient a corticosteroid conjugate.
    Type: Application
    Filed: August 22, 2003
    Publication date: August 12, 2004
    Inventors: Martin H. Teicher, Susan L. Andersen-Navalta